Redoxis

Rwanda
Byumba, Northern Province, Rwanda, 223 81

Company profile

Redoxis company profile

Redoxis is a preclinical CRO with focus on inflammation and autoimmune conditions. They provide in vivo of RA, MS, GBS and SLE. In addition, they have a fully equipped lab with capacity to perform in vitro and ex vivo follow up assays and a wide range of immunology assays to provide you everything form MoA studies to PK and in vivo efficacy studies. Please visit www.redoxis.com for further information or contact us directly for quotes and discussion on model selection (free of charge).

Business identity

Contact email
[email protected]
Phone number
+46707259565
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2007-01-01, Year

Headquarters

Postal code
223 81
Country code
RW
Continent
Africa

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / 2022-01-11
Investors
1
Lead investors
1

Categories and groups

Founders and investors

Lead investors

Eurostars

Investors

Eurostars